Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 4/2018

01-04-2018 | Research Article

Current situation in gynecological oncology training in Spain: where we are and where we want to go

Authors: P. Padilla-Iserte, L. Minig, I. Zapardiel, L. Chiva, R. Laky, J. de Santiago

Published in: Clinical and Translational Oncology | Issue 4/2018

Login to get access

Abstract

Background

It is important to know what a young gynecologic oncologist perceives as a need to achieve a good training in gynecologic oncology.

Objective

This study aims to evaluate the level of training in gynecologic oncology in Spain.

Methods

A Web-based anonymous questionnaire was sent via e-mail to Spanish trainees listed in European Network of Young Gynecological Oncology (ENYGO). The survey was developed in four sections: (1) general training in gynecologic oncology, (2) distribution of current clinical activity, (3) surgical training, and (4) perspective future gynecologic oncology. It contained 51 questions, with multiple-choice answers that had to be answered by the ENYGO members.

Results

The questionnaire was sent to 64 people listed in the ENYGO database. Of these, 37 members responded (response rate of 58%). Overall, more training in surgery is necessary, to perform radical oncological surgeries. It is claimed a sub-specialty recognition, to ensure an equalitarian and homogeneous training.
Literature
1.
Averette HE, Wrennick A, Angioli R. History of gynecologic oncology subspecialty. Surg Clin North Am. 2001;81:747–51.CrossRefPubMed
2.
Vernooij F, Heintz P, Witteveen E, van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol. 2007;105:801–12.CrossRefPubMed
3.
Fung-Kee-Fung M, Kennedy EB, Biagi J, Colgan T, D’Souza D, Elit LM, et al. The optimal organization of gynecologic oncology services: a systematic review. Curr Oncol. 2015;22:e282–93.CrossRefPubMedPubMedCentral
4.
Gershenson DM. The future of gynecologic oncology: are we headed for super-specialization? Gynecol Oncol. 2011;122:3–4.CrossRefPubMed
5.
Cibula D, Kesic V. Surgical education and training in gynecologic oncology I: European perspective. Gynecol Oncol. 2009;114:S52–5.CrossRefPubMed
6.
Gultekin M, Dursun P, Vranes B, Laky R, Bossart M, Grabowski JP, et al. Gynecologic oncology training systems in Europe: a report from the European network of young gynaecological oncologists. Int J Gynecol Cancer. 2011;21:1500–6.CrossRefPubMed
7.
Manchanda R, Halaska MJ, Piek JM, Grabowski JP, Haidopoulos D, Zapardiel I, et al. The need for more workshops in laparoscopic surgery and surgical anatomy for European gynaecological oncology trainees: a survey by the European Network of Young Gynaecological Oncologists. Int J Gynecol Cancer. 2013;23:1127–32.CrossRefPubMed
8.
Cohn DE, Roney JD, O’Malley DM, Valmadre S. Residents’ perspectives on surgical training and the resident-fellow relationship: comparing residency programs with and without gynecological oncology fellowships. Int J Gynecol Cancer. 2008;18:199–204.CrossRefPubMed
9.
Templeton A. Subspecialty training and academic careers. Baillieres Best Pract Res Clin Obstet Gynaecol. 1999;13:423–34.CrossRefPubMed
10.
Minig L, Padilla-Iserte P, Zorrero C. The relevance of gynecologic oncologists to provide high-quality of care to women with gynecological cancer. Front Oncol. 2016;14(5):308.
11.
Manchanda R, Godfrey M, Wong-Taylor LA, Halaska MJ, Burnell M, Grabowski JP, et al. The need for accredited training in gynaecological oncology: a report from the European Network of Young Gynaecological Oncologists (ENYGO). Ann Oncol. 2013;24:944–52.CrossRefPubMed
12.
Dodge JE, Chiu HH, Fung S, Rosen BP. Multicentre study on factors affecting the gynaecologic oncology career choice of canadian residents in obstetrics and gynaecology. J Obstet Gynaecol Can. 2010;32:780–93.CrossRefPubMed
13.
Education and training in Surgery: ESGO Survey (European) presented by Dr L. Chiva. In: 19th International meeting of the European Society of Gynaecological Oncology (Nice, France, October 2015).
14.
Reznick RK, MacRae H. Teaching surgical skills–changes in the wind. N Engl J Med. 2006;355:2664–9.CrossRefPubMed
15.
Metadata
Title
Current situation in gynecological oncology training in Spain: where we are and where we want to go
Authors
P. Padilla-Iserte
L. Minig
I. Zapardiel
L. Chiva
R. Laky
J. de Santiago
Publication date
01-04-2018
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 4/2018
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-017-1744-9

Other articles of this Issue 4/2018

Clinical and Translational Oncology 4/2018 Go to the issue

Brief Research Article

Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer

Research Article

Prediction of neoadjuvant chemotherapy response using diffuse optical spectroscopy in breast cancer

Research Article

High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells

Research Article

Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy

Clinical Guides in Oncology

Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy

Correction

Correction to: High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits